Eylea HD 8 mg (0.07 mL of 114.3 mg/mL solution) injection Images
Generic Name: aflibercept
This medication has been identified as Eylea HD 8 mg (0.07 mL of 114.3 mg/mL solution) injection. It is supplied by Regeneron Pharmaceuticals, Inc.
Eylea HD is used in the treatment of Macular Edema Following Retinal Vein Occlusion ; Macular Degeneration; Diabetic Retinopathy; Macular Edema; Diabetic Macular Edema and belongs to the drug class anti-angiogenic ophthalmic agents. Risk cannot be ruled out during pregnancy. Eylea HD 8 mg (0.07 mL of 114.3 mg/mL solution) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Eylea HD
- Generic Name
- aflibercept
- Strength
- 8 mg (0.07 mL of 114.3 mg/mL solution) injection
- Availability
- Prescription only
- Drug Class
- Anti-angiogenic ophthalmic agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Regeneron Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 61755-0050
More about Eylea HD (aflibercept ophthalmic)
- Compare alternatives
- Pricing & coupons
- Reviews (2)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-angiogenic ophthalmic agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
